Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe W Gray

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
BMC Medicine|December 17, 2009
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, et al.
Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Plos One|February 23, 2012
Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcomeDavid A Engler, Sumeet Gupta, Whitfield B Growdon, et al.
BMC Medical Genomics|February 21, 2009
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysYuker Wang, Victoria E H Carlton, George Karlin-Neumann, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
NPJ Precision Oncology|March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analyticsAllen Li, Jamie M Keck, Swapnil Parmar, et al.
Cancer Research|September 17, 2005
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinomaAngela Bik-Yu Hui, Yvonne Yan-Yan Or, Hirokuni Takano, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
BMC Medicine|December 17, 2009
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, et al.
Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Plos One|February 23, 2012
Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcomeDavid A Engler, Sumeet Gupta, Whitfield B Growdon, et al.
BMC Medical Genomics|February 21, 2009
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysYuker Wang, Victoria E H Carlton, George Karlin-Neumann, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
NPJ Precision Oncology|March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analyticsAllen Li, Jamie M Keck, Swapnil Parmar, et al.
Cancer Research|September 17, 2005
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinomaAngela Bik-Yu Hui, Yvonne Yan-Yan Or, Hirokuni Takano, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Pageof 27